Page last updated: 2024-11-01

omeprazole and Hyperprolactinaemia

omeprazole has been researched along with Hyperprolactinaemia in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"A case of a 13 year old girl who manifested hyperprolactinaemia and galactorrhea induced by Omeprazole, a commonly used proton pump inhibitor is presented."3.76Hyperprolactinaemia induced by proton pump inhibitor. ( Farrukh, SN; Jabbar, A; Khan, R, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabbar, A1
Khan, R1
Farrukh, SN1

Other Studies

1 other study available for omeprazole and Hyperprolactinaemia

ArticleYear
Hyperprolactinaemia induced by proton pump inhibitor.
    JPMA. The Journal of the Pakistan Medical Association, 2010, Volume: 60, Issue:8

    Topics: Adolescent; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Galactorrhea; Helicobacter Infections; Hel

2010